Xeris Biopharma Holdings, Inc.
XERS
11 insider filings · Latest: Jun 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5 6:29 PM | Marla PerskyDirector | Sale | 15,500 | $5.90 | $91.4K | 126,500(D) | View → |
| Jun 4, 2026 | Jun 5 6:18 PM | Dawn HalkuffDirector | Sale | 20,000 | $6.09 | $121.9K | 95,000(D) | View → |
| Jun 4, 2026 | Jun 5 6:18 PM | Barbara-Jean Anne Bormann-KennedyDirector | Sale | 16,000 | $6.09 | $97.5K | 126,500(D) | View → |
| Jun 4, 2026 | Jun 5 6:17 PM | John JohnsonDirector | Sale | 15,000 | $6.09 | $91.4K | 683,083(D) | View → |
| Jun 1, 2026 | Jun 2 6:05 PM | Beth HechtChief Legal Officer and Corporate Secretary | Sale | 16,667 | $6.06 | $101.0K | 1,176,506(D) | View → |
| May 1, 2026 | May 1 5:50 PM | Beth HechtChief Legal Officer and Corporate Secretary | Sale | 16,667 | $6.23 | $103.8K | 1,193,173(D) | View → |
| Apr 1, 2026 | Apr 3 5:45 PM | Beth HechtChief Legal Officer and Corporate Secretary | Sale | 16,667 | $5.99 | $99.9K | 1,209,840(D) | View → |
| Mar 30, 2026 | Apr 1 5:54 PM | James Aloysius BradyDirector | Sale | 10,834 | $5.54 | $60.0K | 89,166(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 5 6:39 PM | Garheng KongDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Jun 4, 2026 | Jun 5 6:29 PM | Marla PerskyDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Jun 4, 2026 | Jun 5 6:18 PM | Dawn HalkuffDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Jun 4, 2026 | Jun 5 6:18 PM | Barbara-Jean Anne Bormann-KennedyDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Jun 4, 2026 | Jun 5 6:17 PM | John JohnsonDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Jun 4, 2026 | Jun 5 6:16 PM | James Aloysius BradyDirector | Grant/Award | 32,996 | $6.15 | 32,996(D) | View → |
| Mar 12, 2026 | Mar 16 6:11 PM | Kevin MccullochPresident and Chief Operating Officer | Option Exercise | 48,898 | $4.09 | 79,996(D) | View → |